769 results on '"Triggiani, Massimo"'
Search Results
52. Avapritinib versus Placebo in Indolent Systemic Mastocytosis
53. Multicentric Observational Study on Safety and Tolerability of COVID-19 Vaccines in Patients with Angioedema with C1 Inhibitor Deficiency: Data from Italian Network on Hereditary and Acquired Angioedema (ITACA)
54. Secretory and Membrane-Associated Biomarkers of Mast Cell Activation and Proliferation
55. Urticarial Vasculitis. A Review of the Literature
56. Urticaria: recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental Dermatology
57. Supplemental Table S3 from Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future
58. Data from Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future
59. Legends of Allergy: Gianni Marone
60. Disease correlates and clinical relevance of hereditary α-tryptasemia in patients with systemic mastocytosis
61. Avapritinib Improved Symptoms and Quality of Life in Patients With Indolent Systemic Mastocytosis in the PIONEER Study
62. Efficacy and Safety of Avapritinib in Indolent Systemic Mastocytosis (ISM): Results from the Double Blinded Placebo-Controlled PIONEER Study
63. Risk of Death, Thrombotic and Hemorrhagic Events in Patients with Atrial Fibrillation and Systemic Autoimmune Diseases. An Analysis from a Global Federated Dataset
64. Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry
65. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis
66. Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases
67. Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology
68. Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps
69. Role of Mast Cells in Diseases
70. Mastocytosis
71. Mast Cell Mediators
72. Pitfalls in anaphylaxis
73. In memoriam: Lawrence M. Lichtenstein (1934–2022)
74. Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion
75. Human Macrophages and Monocytes Express Functional Na+/Ca2+ Exchangers 1 and 3
76. Potential benefit of omalizumab in respiratory diseases
77. Immunopharmacological modulation of mast cells
78. Fragments of truth: T-cell targets of polyclonal immunoglobulins in autoimmune diseases
79. MPN-274 Avapritinib in Patients With Advanced Systemic Mastocytosis (AdvSM): Efficacy and Safety Analysis From the Phase 2 PATHFINDER Study With 3-Year Follow-up
80. Avapritinib in Patients With Advanced Systemic Mastocytosis (AdvSM): Efficacy and Safety Analysis From the Phase 2 PATHFINDER Study With 3-Year Follow-up
81. Biomarkers for evaluation of mast cell and basophil activation
82. La triptasi sierica nella diagnosi di mastocitosi sistemica in pazienti adulti senza lesioni cutanee
83. Drug-induced mast cell eradication: A novel approach to treat mast cell activation disorders?
84. Clinical impact and proposed application of molecular markers, genetic variants, and cytogenetic analysis in mast cell neoplasms: Status 2022
85. Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels in primary antiphospholipid syndrome. The multicenter ATHERO-APS study
86. Emerging drugs for the treatment of hereditary angioedema due to C1-inhibitor deficiency
87. Remodeling of arachidonic acid in inflammatory cells of the human lung
88. Evaluation of vaccination safety in children with mastocytosis
89. International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency
90. Role of basophils in airways inflammation
91. Pancarditis as the Clinical Presentation of Eosinophilic Granulomatosis with Polyangiitis: A Multimodality Approach to Diagnosis
92. Immunohistochemical algorithms and gene expression profiling in primary cutaneous B-cell lymphoma
93. Cardiac and vascular features of arterial and venous primary antiphospholipid syndrome. The multicenter ATHERO-APS study
94. Mast Cell Activation Syndromes: Collegium Internationale Allergologicum Update 2022
95. Vascular endothelial growth factors and angiopoietins as new players in mastocytosis. (VARRICCHI AUTORE CORRISPONDENTE)
96. Current Take on Systemic Sclerosis Patients’ Vaccination Recommendations
97. Screening for Hereditary Alpha-Tryptasemia in Subjects with Systemic Mastocytosis (SM) and Non-SM Mast Cell Activation Symptoms
98. Severe asthma: One disease and multiple definitions
99. Real-Life Effectiveness of Mepolizumab on Forced Expiratory Flow between 25% and 75% of Forced Vital Capacity in Patients with Severe Eosinophilic Asthma
100. Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.